Faculty Opinions recommendation of Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder.

Dan Joseph Stein

doi:10.3410/f.733569758.793580442

Faculty Opinions recommendation of Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder. — Dan Joseph Stein | RDL Network

Faculty Opinions recommendation of Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder.

Discussion(0)

Related publications

Faculty Opinions recommendation of Sex differences in the genetic architecture of obsessive-compulsive disorder.

Faculty Opinions recommendation of Blood-based dynamic genomic signature for obsessive-compulsive disorder.

Faculty Opinions recommendation of Shared genetic etiology between obsessive-compulsive disorder, obsessive-compulsive symptoms in the population, and insulin signaling.

Faculty Opinions recommendation of Maternal Effects as Causes of Risk for Obsessive-Compulsive Disorder.

Antidepressant-Induced Mania in Obsessive-Compulsive Disorder